News and Announcements
MedAdvisor International Pty Ltd (ASX:MDR) Annual Update 2015; Lists on the ASX & Establishes Important Partnerships
- Published January 05, 2016 2:53PM UTC
- Publisher Wholesale Investor
- Categories Company Updates
2015 Highlights:
- Raises $5m in oversubscribed public offer
- Commences trading on the ASX under ticker code MDR
- Announces new medication training relationship with Amgen
- Share price up 90% since listing
- Established important partnerships with pharmaceutical companies GSK, UCB, AstraZeneca and Apotex, as well as private health insurer, BUPA
- One quarter of Australian pharmacies subscribed to the MedAdvisor platform
MedAdvisor International Pty Ltd is an Australian medical technology business focused on designing and commercialising world class software platforms for medication management on mobile and internet devices. MedAdvisor’s Platform connects to pharmacy dispensing systems, automatically retrieving medication records and driving an intelligent training, information and reminder system to ensure correct and reliable medication use.
MedAdvisor has established strategic partnerships with Bupa Australia and most recently, distribution partner Apotex Australia. The company is also supported by Australia’s major pharmacies including Amcal, Chemmart, Terry White Chemists, Guardian Pharmacy and more.
Company Updates
Capital Is Flowing – Just Not to Everyone: Inside Australia’s $1.8 Billion Q1 2026
Australia’s startup ecosystem opened 2026 with a number that demanded attention. In the first three months of the year, $1.8 billion was raised across 81 venture deals and 26 accelerator rounds. That makes Q1 2026 the strongest start to a year since the 2022 boom, up 63% on Q1 2025, and more than double the […]
The control layer for the electrified home
THE MARKET SHIFT Australian households have been pulled into a real-time energy market they never knowingly signed up for. Flat electricity tariffs are disappearing. In their place: dynamic, time-of-use pricing that changes depending on when power is consumed. Electricity is now cheapest when solar floods the grid in the middle of the day — and […]
500 Million Episodes, Limited Treatment: How Patrys is Bridging the Gap in an Underserved Market
In the clinical vocabulary of the Intensive Care Unit, there is perhaps no word that carries as much quiet dread as delirium. It is a “chemical storm” of the brain—an acute dysfunction where the delicate balance between calming and activating signals is scrambled. For the patient, it can be a waking nightmare of hallucinations and […]
Backed By Leading Investment Groups and Family Offices
